Recruiting

VItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma

The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.

ClinicalTrials.gov IDNCT06570889
PhasePHASE3
Enrollment2000
SponsorProfessor Klaus Bønnelykke
Age18 Years
SexFEMALE
I'm interested View official listing

Conditions studied

Asthma, Respiratory Tract Infections, Gastrointestinal Infection, Croup, Eczema, Allergy, Wheezing, Fractures, Bone, Development, Child, Cognition Disorders in Children, Psychiatric Diagnosis

About this study

The overall aim of the study is to develop a nutritional preventive vitamin D supplementation strategy in pregnancy for early childhood asthma/persistent wheeze during the first three years of life as we hypothesize that supplementation in higher doses than recommended could reduce the risk of disease development.

Interventions

Primary outcomes

Eligibility information

* Pregnant Danish women before week 26 with blood levels of EPA+DHA above 4.7% of total fatty acids * No current vitamin D intake above the recommended 400 IU/day * No endocrine-, heart-, kidney- or auto-immune disorders * No disorders requiring treatment with blood thinning medication

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.